Intelligence Dashboards

Upcoming FDA target action dates. Know when approval decisions are expected.

Track Phase 1-4 trial activity by company. See who has the strongest clinical pipeline.

Deep dive into any company's trial portfolio by therapeutic area and phase.

See who's competing in each indication. Trial counts, sponsors, and phase breakdown.

Rising and falling indications based on trial activity over time.

FDA-approved biosimilars, reference products, and market leaders.

Drugs losing exclusivity by year with Medicare Part D spending data. Not total revenue.

Trial activity and competition by indication. Identify concentrated vs fragmented markets.

Competitive density heatmap across all therapeutic areas.

Head-to-head comparison of any two company portfolios.

Browse the indication taxonomy and see coverage metrics.